“PHARMACOLOGIC TOPOISOMERASE-I INHIBITION CAUSES DNA DAMAGE AND MORTALITY IN ACTIVATED CD4+ T CELLS”. Genetics & Applications, vol. 2, no. 2, Dec. 2018, pp. 51-56, https://doi.org/10.31383/ga.vol2iss2pp51-56.